Serum Phosphate Predicts Early Mortality in Adults Starting Antiretroviral Therapy in Lusaka, Zambia: A Prospective Cohort Study

Douglas C. Heimburger, John R. Koethe, Christopher Nyirenda et al. · 2010

Read Serum Phosphate Predicts Early Mortality in Adults Starting Antiretroviral Therapy in Lusaka, Zambia: A Prospective Cohort Study by Douglas C. Heimburger, John R. Koethe, Christopher Nyirenda et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0010687.txt.

Description

Douglas Heimburger and colleagues followed adults starting HIV treatment in Lusaka, Zambia, in PLOS ONE in 2010. Death rates run high in the first weeks of antiretroviral therapy in much of Africa. Clinics with few lab tests need simple signs that flag who is in danger.

The team tracked blood phosphate, a cheap and common test, from the start of treatment. Low or falling phosphate marked patients more likely to die early. The link held even after other risk signs were counted. A low-cost flag like this could steer food support and close watching toward the patients who need them most.

Catalog record

CREATORDouglas C. Heimburger, John R. Koethe, Christopher Nyirenda et al.
YEAR2010
COLLECTIONPAPERS
FORMATTXT
FILE SIZE33 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0010687

Browse the full library · About the Tower of Babel